Home » Topics » BioWorld Science

BioWorld Science
RSS

Zeneca and Rutgers collaborate on apoptosis research

Dec. 4, 1996

Beacon Diagnostics launches first product

Dec. 4, 1996

Eight presentations at the RSNA on EchoGen

Dec. 4, 1996

Eastern European approval for Zila's oral cancer diagnostic

Dec. 4, 1996

Schering-Plough continues research into FPTase inhibitors

Dec. 4, 1996

New bisphosphonic acid derivatives from Nippon Chemiphar

Dec. 4, 1996

JT discloses new compounds for Alzheimer's disease and other CNS disorders

Dec. 4, 1996

New endothelin receptor modulators reported by Texas Biotechnology

Dec. 4, 1996

EGFR tyrosine kinase inhibitors from Ciba-Geigy for hyperproliferative conditions

Dec. 4, 1996

PDE IV inhibitors/cytokine inhibitors disclosed by Janssen

Dec. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...